Nebenwirkungen · Dasselta
Dasselta 5 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 4
HOS-214243 · Präparat HOS-155304
System Organ Class Frequency Adverse reactions seen with desloratadine Metabolism and nutritional Not known Increased appetite disorders Psychiatric disorders Very rare Hallucinations Not known Abnormal behaviour*, aggression*, depressed mood Nervous system disorders Common Headache Very rare Dizziness, somnolence, insomnia, psychomotor hyperactivity, seizures Eye disorders Not known Eye dryness Cardiac disorders Very rare Tachycardia, palpitations Not known QT prolongation* Gastrointestinal disorders Common Dry mouth Very rare Abdominal pain, nausea, vomiting, dyspepsia, diarrhoea Hepatobiliary disorders Very rare Elevations of liver enzymes, increased bilirubin, hepatitis Not known Jaundice Skin and subcutaneous tissue Not known Photosensitivity disorders Musculoskeletal and connective Very rare Myalgia tissue disorders General disorders and Common Fatigue administration site conditions Very rare Hypersensitivity reactions (such as anaphylaxis, angioedema, dyspnoea, pruritus, rash, and urticaria) Not known Asthenia Investigations Not known Weight increased * Undesirable effects reported during the post-marketing period also in paediatric patients.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-06-05T02:00:00Z · SHA-256 ea9fd4d7380e4968a35859d3c6a0c67e4addaad467c2ae99b18764e600cbdc51 · Passage ff0497da43ca810fd19904731938a1809541b2f3a69f5f1874153d3f612999cf · Zeichen 934–3360 im Abschnitt